Don’t foresee any disruptions due to Covid-19: Vasant Narasimhan, CEO, Novartis

Novartis is one of the oldest pharma MNCs known for anti-cancer and anti-diabetic drugs. Despite the patent expiry for its popular anti-diabetic drug Galvus, Narasimhan is upbeat about Novartis’ India prospects.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2UZPgWp
via IFTTT